These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 18182409

  • 1. The impact of sex in primary glomerulonephritis.
    Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [Abstract] [Full Text] [Related]

  • 2. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 3. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [Abstract] [Full Text] [Related]

  • 4. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [Abstract] [Full Text] [Related]

  • 5. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 6. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
    Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group.
    J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
    [Abstract] [Full Text] [Related]

  • 7. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
    Weber CL, Rose CL, Magil AB.
    Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
    [Abstract] [Full Text] [Related]

  • 8. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Feb; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 9. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Feb; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 10. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Feb; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 11. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A, Perugini C, Seccia M, Napodano P, D'Amico G, Bellomo G.
    J Nephrol; 2002 Feb; 15(4):349-57. PubMed ID: 12243363
    [Abstract] [Full Text] [Related]

  • 12. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK, Yan HD, Hewitson TD, Nicholls KM, Fairley KF, Kincaid-Smith P, Becker GJ.
    Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
    [Abstract] [Full Text] [Related]

  • 13. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T, Lepenies J, Nightingale P, Howie AJ, Adu D, Harper L.
    Nephron Clin Pract; 2009 Oct; 112(1):c16-24. PubMed ID: 19342865
    [Abstract] [Full Text] [Related]

  • 14. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
    Heering P, Schneider A, Grabensee B, Plum J.
    Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659
    [Abstract] [Full Text] [Related]

  • 15. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov 05; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 16. Renal pathology in idiopathic membranous nephropathy: a new perspective.
    Troyanov S, Roasio L, Pandes M, Herzenberg AM, Cattran DC.
    Kidney Int; 2006 May 05; 69(9):1641-8. PubMed ID: 16572119
    [Abstract] [Full Text] [Related]

  • 17. [Factors predicting for renal survival in primary focal segmental glomerulosclerosis].
    Roja JR, Pérez M, Hurtado A, Asato C.
    Nefrologia; 2008 May 05; 28(4):439-46. PubMed ID: 18662153
    [Abstract] [Full Text] [Related]

  • 18. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H.
    Ren Fail; 2005 May 05; 27(1):45-52. PubMed ID: 15717634
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
    Deegens JK, Wetzels JF.
    Minerva Urol Nefrol; 2005 Sep 05; 57(3):211-36. PubMed ID: 15986018
    [Abstract] [Full Text] [Related]

  • 20. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 05; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.